Incentive Stock Program

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Note 7 — Incentive Stock Program

In the first nine months of 2022, Abbott granted 2,634,647 stock options, 514,205 restricted stock awards and 5,427,697 restricted stock units under its incentive stock program. At September 30, 2022, approximately 87 million shares were reserved for future grants. Information regarding the number of options outstanding and exercisable at September 30, 2022 is as follows:


	Outstanding		Exercisable
Number of shares	29,048,449		23,310,464
Weighted average remaining life (years)	5.4		4.6
Weighted average exercise price	$	70.22	$	59.69
Aggregate intrinsic value (in millions)	$	901	$	890

The total unrecognized share-based compensation cost at September 30, 2022 amounted to approximately $600 million which is expected to be recognized over the next three years.